A study in humans demonstrated that the mir-760 is downregulated in hypertrophic scar tissue compared to normal tissue [Siu et al. DOI:10.1111/wrr.13100], while a separate investigation in human heart failure patients after acute myocardial infarction found it was upregulated in peripheral blood mononuclear cells from individuals with sacubitril/valsartan resistance compared to non-resistant patients [Su et al. DOI:10.1016/j.ejphar.2023.175547].